Welcome to "The Poster!" To become a subscriber and start getting updates on new content, subscribe now!
In the News
Community | Last Call to Try Your Hand at Volunteering This Take Your Child to Work Day
If last year was any indicator, plenty of kids will be eager to participate in NCI Frederick’s Take Your Child to Work Day this summer. Last year’s event, the first since the pandemic began, welcomed more than 120 children. Volunteering to sponsor a program or hub activity will help guarantee this year’s crowd—which is expected to be larger—has a fun-filled and educational day in science.
Science & Technology | Start Your Engines: Pandemic Lockdown Contributed to Team’s Discovery of Bacterial Motor Function
The lockdowns during 2020, the first year of the COVID-19 pandemic, temporarily paused most laboratory work, but they didn’t stop science from moving forward. Many scientists, including those comprising what’s now NCI’s Center for Structural Biology (CSB), seized the opportunity while out of the lab to revisit previously collected data. Those efforts are paying off.
Events | ‘What a Scientist Looks Like’: Women in Science Describe Adversity and Success
There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four panelists at Women in Science Speak 2024. The panel marked the International Day of Women and Girls in Science and celebrated empowerment and mentorship among women in science.
Events | Goings Claims the Gold as OHS Rekindles Chili Cook-off
NCI Frederick has a new chili champion. Dawn Goings, administrative assistant in Environment, Health, and Safety, blazed her way through a heated competition to clinch first place in the 17th Chili Cook-off. The cook-off, a storied lunch-hour tradition at NCI Frederick, returned to campus this year for the first time since 2019, rising phoenix-like from the ashes of the pandemic.
Science & Technology | Enhanced Antibody-Drug Conjugate Eradicates Large Breast Cancer Tumors in Experimental Models
Most available antibody-drug conjugates offer limited improvement and can still be toxic. But a study conducted by researchers in the National Cancer Institute’s Center for Cancer Research and published in Cell Reports in December 2023 highlights a new ADC—carefully engineered, screened, and purified—that can eradicate large tumors in animal models at a dose per body weight that humans can tolerate.